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ABSTRACT
Cpf1s, the RNA-guided nucleases of the class II
clustered regularly interspaced short palindromic re-
peats system require a short motive called proto-
spacer adjacent motif (PAM) to be present next to
the targeted sequence for their activity. The TTTV
PAM sequence of As- and LbCpf1 nucleases is rel-
atively rare in the genome of higher eukaryotic or-
ganisms. Here, we show that two other Cpf1 nucle-
ases, Fn- and MbCpf1, which have been reported to
utilize a shorter, more frequently occurring PAM se-
quence (TTN) when tested in vitro, carry out efficient
genome modification in mammalian cells. We found
that all four Cpf1 nucleases showed similar activi-
ties and TTTV PAM preferences. Our approach also
revealed that besides their activities their PAM pref-
erences are also target dependent. To increase the
number of the available targets for Fn- and MbCpf1
we generated their RVR and RR mutants with altered
PAM specificity and compared them to the wild-type
and analogous As- and LbCpf1 variants. The mutants
gained new PAM specificities but retained their activ-
ity on targets with TTTV PAMs, redefining RR-Cpf1’s
PAM-specificities as TTYV/TCCV, respectively. These
variants may become versatile substitutes for wild-
type Cpf1s by providing an expanded range of targets
for genome engineering applications.
INTRODUCTION
Some bacterial and archaeal clustered regularly interspaced
short palindromic repeats (CRISPR)-associated nucleases
(Cas) have been repurposed for genome modifications (1–
4), transcription modulation (5–8) and chromosome imag-
ing (9–12) in eukaryotic cells. The area of their application
is continuously widening owing to the simplicity of repro-
gramming their target specificity. These nucleases harbor a
guide RNA that directs the cleavage of available comple-
mentary sequences. The complementary sequence (proto-
spacer) needs to be accompanied by a short protospacer
adjacent motif (PAM) to be recognized and cleaved by
these Cas nucleases (13–15). Beside the most frequently em-
ployed Streptococcus pyogenes Cas9 (SpCas9), several Sp-
Cas9 counterparts from other organisms [such as Staphy-
lococcus aureus (Sa), Streptococcus thermophilus (St) and
Neisseria meningitidis (Nm)] have been exploited (16–18);
however, their versatility and activity in mammalian cells
have not surpassed those of SpCas9 (16,19,20).
Recently, the newly discovered Cpf1 (CRISPR from Pre-
votella and Francisella 1 or Cas12a) nucleases [class II, type
VA (21,22)] have also been repurposed for genome engi-
neering in mammalian and plant cells. They offer several
features distinct from Cas9 nucleases, such as (i) produc-
ing 5′ overhangs, (ii) utilization of a shorter guide RNA,
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(iii) recognition of T-rich PAM sequences, (iv) having a
longer distance between the seed sequence and the cleav-
age site (20,23) and (v) processing their own crRNA (24).
In the pioneering study, Zetsche et al. analyzed 16 Cpf1 nu-
cleases for their PAM requirements in vitro exploring one
target sequence. Eight nucleases showed activity that was
further characterized in mammalian cells on another tar-
get (23). Their analyses revealed that these nucleases ex-
ploited thymidine-rich PAM sequences of various lengths,
ranging from 2 to 5 nucleotides (23). However, they found
that only two of them, As- (Acidaminococcus sp. BV3L6)
and Lb- (Lachnospiraceae bacterium MA2020) Cpf1 nu-
cleases demonstrated substantial activity in mammalian
HEK293FT cells (23). Subsequent studies provided more
details about their mechanism of action by determining
their crystal structure (25–27), by discerning the activi-
ties of their nuclease domains (25–27) and by uncovering
their RNA processing activity (28). In comparison with Sp-
Cas9, a lower off-target propensity is also suggested for
these Cpf1s (29,30). As- and LbCpf1 nucleases have been
successfully employed for genome engineering in human
HEK293 (23,24,29–31), humanU2OS (30), silkworm BmN
(32), mouseN2a (19) andmouse primary neural (24) cells as
well as in mouse (24,33–35), Xenopus (36), zebrafish (36),
rice (37–41), tobacco (42), soybean (42) and cyanobacteria
(43) species. These nucleases induce indels (short insertions
or deletions) with efficiencies comparable to those of Sp-
Cas9 in HEK293 cells (23,29,30). In contrast, these Cpf1s
demonstrated lower homology-directed repair- (HDR), in-
ducing activities, than SpCas9, but comparable to those of
the Cas9 counterparts’ (Sa-, St- and NmCas9) when exam-
ined in N2a cells (19). These differences may be attributable
to the different repair systems exploited or to the different
cells employed.
Regarding their PAM preferences, AsCpf1 showed an ex-
clusive preference for three T nucleotides (TTTN), while
LbCpf1 seems to bemore permissive for a C nucleotide sub-
stitution in its TTTN PAM sequence requirement in vitro
(23). From the co-crystal structure of AsCpf1, crRNA and
target DNA, it is concluded that the three thymidine bases,
but not the unrestricted N base of the PAM sequence, inter-
act with theAsCpf1 protein, supporting the reportedTTTN
PAM sequence requirement (25). A later study found that
a preference for the three T nucleotides is also evident in
mammalian cells; however, both nucleases disfavor T at po-
sition -1 leading to a TTTV PAM requirement (31,44–46).
One of the disadvantages of Cpf1-based genome edit-
ing is the relatively rare occurrence of the three-thymidine-
long PAM sequences of As- and LbCpf1s. Here we aim to
test the applicability of MbCpf1 (Moraxella bovoculi 237)
and FnCpf1 (Francisella novicida U112) nucleases which
were reported to have shorter, two-thymidine-long PAM
sequences (23) for efficient genome engineering in mam-
malian cells.
Another approach to extend the available target space for
Cpf1 nucleases is to generate mutant variants with altered
PAM specificities. Recently, it was reported that mutating
the serine 542, lysine 548 and asparagine 552 amino acids
to arginine-valine-arginine (RVR mutant) alters the PAM
specificity of AsCpf1 to include TATV PAMs, while an-
other mutation combination (S542R+K607R, RR mutant)
results in increased activity on targets with TYCV PAMs
(44). Here we generate analogous RVR and RR mutant
variants of Fn- and MbCpf1 and characterize them in re-
lation to the As- and LbCpf1 variants.
MATERIALS AND METHODS
Materials
Restriction enzymes and T4 ligase were purchased from
Thermo Fischer Scientific. DNA oligonucleotides were
acquired from Sigma-Aldrich. All DNA constructs
were verified by Sanger sequencing (Microsynth AG).
Plasmids were purified with GenElute HP Plasmid
Miniprep kit (Sigma-Aldrich). Q5 polymerase was from
New England BioLabs Inc. Dulbecco’s modified Ea-
gle’s Medium, foetal bovine serum, Turbofect, penicillin
and streptomycin were acquired from Thermo Fisher
Scientific. The following plasmids were gifts from Feng
Zhang (Addgene numbers: pY004 (pcDNA3.1-hFnCpf1)
#69976 (23), pY014 (pcDNA3.1-hMbCpf1) #69986
(23), pY210 [pcDNA3.1-hAsCpf1(TYCV)] #89351 (44),
pY220 ([pcDNA3.1-hAsCpf1(TATV)] #89353 (44), pY230
[pcDNA3.1-hLbCpf1(TYCV)] #89355 (44), px330-U6-
Chimeric BB-CBh-hSpCas9 #42230 (2)).
Plasmid construction
Vectors were constructed using standard molecular biol-
ogy techniques. For details see Supplementary Information.
The sequences of DNA oligonucleotides used in these stud-
ies are listed in Supplementary Tables S1, S2, S3, S4 and
S5.
Deposited plasmids are summarized in Supplementary
Table S6.
Cell culturing and transfection
N2a cells (Neuro-2a mouse neuroblastoma cells, ATCC
– CCL-131) were grown at 37◦C in a humidified atmo-
sphere of 5% CO2 in high glucose Dulbecco’s Modified Ea-
gle medium (DMEM) supplemented with 10% heat inacti-
vated fetal bovine serum, 4 mM L-glutamine (Gibco), 100
units/ml penicillin and 100 g/ml streptomycin.
HEK-293.GFP cells were generated, maintained and
transfected as described in (47).
Modified GFxFP assay. Cells were seeded onto 48-well
plates a day before transfection at a density of 3 × 104
cells/well. The next day, at around 40% confluence, cells
were transfected with plasmid constructs using Turbofect
reagent, briefly as follows: 250 ng total plasmid DNA (2
ng GFxFP plasmid, 124 ng crRNA and nuclease expres-
sion plasmid, and 124 ng mCherry expression plasmid to
monitor the transfection efficiency) and 1l Turbofect were
mixed in 50 l serum-free DMEM and the mixture was in-
cubated for 30 min at room temperature prior to adding
to cells. Three parallel transfections were made from each
sample. Cells were analyzed by flow cytometry 2 days post
transfection.
Genomic HDR assays were carried out as described in
(19).
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GFP disruption assay was carried out as described in
(47).
Flow cytometry
Flow cytometry analysis was carried out on either an At-
tune Acoustic Focusing Cytometer (Applied Biosystems
by Life Technologies) or a CytoFLEX 2000 (Life Tech-
nologies Ltd.) device. For data analysis, Attune Cytomet-
ric Software and CytExpert 1.2 software were used, respec-
tively. In all experiments, a total of 10 000 viable single
cells were acquired and were gated based on side and for-
ward light-scatter parameters. Cells expressing GFP and
mCherry from a control plasmid were used to adjust the
parameters for the identification of GFP and mCherry pos-
itive cells in the samples. TheGFP signal was detected using
the 488 nm diode laser for excitation and either the 530/30
nm filter of the Attune Acoustic Focusing Cytometer or the
525/40 nm filter of the CytoFLEX 2000 for emission. The
mCherry signal was detected using the 488 nm diode laser
for excitation and a 640LP filter for emission in the case of
the Attune Acoustic Focusing Cytometer, and the 638 nm
diode laser for excitation and an 660/20 nm filter for emis-
sion in the case of the CytoFLEX 2000.
Next-generation sequencing
HEK293 cells were seeded onto 48-well plates a day be-
fore transfection at a density of 2 × 104 cells/well. The
next day, at around 25% confluence, cells were transfected
with plasmid constructs using Jetfect reagent (Biospiral-
2006. Ltd.), briefly as follows: 234 ng total plasmid DNA
(97 ng crRNA and mCherry expression plasmid, and 137
ng nuclease expression plasmid) and 1 l LP-25 reagent
were mixed in 50 l serum free DMEM and the mixture
was incubated for 30 min at room temperature prior adding
to cells. Three parallel transfections were made from each
sample. Transfection efficiency was analyzed by flow cy-
tometry 5 days post transfection via mCherry fluorescence.
Then cells were centrifuged at 1000 × g for 10 min and ge-
nomic DNA was purified according to Puregene DNA Pu-
rification protocol (Gentra Systems). Amplicons for deep
sequencing were generated using two rounds of PCR by
Q5 high fidelity polymerase to attach Illumina handles. The
first step PCR primers used to amplify target genomic se-
quences are listed in Supplementary Table S7. After being
quantified with Qubit dsDNA HS Assay kit (Invitrogen)
PCR products were pooled for deep sequencing. Sequenc-
ing on Illumina Miseq instrument was performed by AT-
GandCo Ltd. Indels were counted computationally among
reads thatmatched at least 75% to the first 20 bp of the refer-
ence amplicon. Indels andmismatches were searched at±60
bp around the cut site. For each sample, the indel frequency
was determined as (number of readswith an indel)/(number
of total reads). Average reads per sample was 23 398 with a
minimum as 8133. No sample was excluded due to fewer
than 1000 total reads. The following software were used:
BBMap 38.08, samtools 1.8, BioPython 1.71, PySam 0.13.
SRA accession: SRP155357.
RESULTS
Mb- and FnCpf1 nucleases have comparable on-target activ-
ity to that of As- and LbCpf1 in mammalian cells employing
a GFxFP reporter assay
Since As- and LbCpf1 demonstrated higher activities when
their crRNAs were expressed from a plasmid instead of
from a PCR product (19), we introduced a human U6
promoter driven crRNA cassette into pY004-pcDNA3.1-
hFnCpf1 and pY014-pcDNA3.1-hMbCpf1 vectors (Ad-
dgene numbers: #69976 and #69986, respectively) (23)
(Supplementary Figure S1). In order to monitor the activ-
ity of Mb- and FnCpf1 nucleases we cloned thirteen dif-
ferent, randomly picked spacer sequences into these vec-
tors (Supplementary Table S1). To test the cleavage effi-
ciency of Cpf1 nucleases in mammalian cells, we employed
a GFxFP reporter assay previously reported (Supplemen-
tary Figure S2 and Supplementary Table S2) (19) that is
based on the recovery of an interrupted GFP (green fluo-
rescent protein) sequence containing about 500 nucleotide-
long homologous stretches. The assay was refined for this
study by altering the ratios of the transfected plasmids in a
way that dramatically decreased the background GFP level
(below 1–2%) in N2a cells. The cleavage efficiency of the
Lb-, As-, Mb- and FnCpf1 nucleases was comparable
when assessed on the same targets with three-thymidine-
nucleotide PAM sequence (Figure 1, Supplementary Fig-
ure S3); however, LbCpf1 seems to perform slightly bet-
ter. To provide appropriate controls, we generated two in-
activated RuvC nuclease domain mutants for each of the
three Cpf1 nucleases (As-, Lb- and MbCpf1) based on the
sequence similarity of these nucleases and the inactivating
mutations identified in an earlier study (23), which in the
case of FnCpf1 were the D917A and E1006A substitutions
(23). Bothmutations were equally effective in abolishing the
activities of these Cpf1 nucleases, resulting in no detectable
activity in the GFxFP assay (Supplementary Figure S4 and
Supplementary Table S3) for both. These results agree with
those of Yamano et al. (25).
On the basis of these results on the activity of Fn- and
MbCpf1 employing a plasmid-based assay system, we ex-
amined their homology-directed recombination inducing
activity on genomic targets.
Homology directed recombination-inducing activity of differ-
ent Cpf1 nucleases on targets with TTTN PAM sequence in
mouse genomic environment
We examined the HDR-inducing activities of the four
Cpf1 nucleases on the mouse Prnd gene exploiting six dif-
ferent target sequences (PRND 1–6). For these experi-
ments, we generated two homologous recombination donor
molecules, one with homologous arms matching the Prnd
locus (pHRdonor-EGFP-Dpl1000) and another one with
homologous arms directed to a different genomic locus
(Sprn locus: pHRdonor-EGFP-Sho1000) to be used here
as a control. Both donor molecules contain a GFP expres-
sion cassette. To see if the selected genomic target-positions
are indeed available for RNA-guided nucleases, we ana-
lyzed the HDR-inducing activity of SpCas9 on overlapping
positions with the Cpf1 targets (Supplementary Table S4).
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Figure 1. Comparison of cleavage efficiencies of different Cpf1 nucleases in
GFxFP plasmid-based assay in mouse N2a cells. Percentages of GFP pos-
itive cells counted above the background level, resulting from the action
of various nucleases (blue – LbCpf1, orange – AsCpf1, green – FnCpf1,
yellow –MbCpf1). Thirteen randomly picked targets cloned into the pGF-
ori-FP vector (19) were tested using the GFxFP assay. The target vectors
along with the corresponding nuclease vector were transfected into N2a
cells and GFP positive cells were counted 2 days after transfection. All
samples are also cotransfected with an mCherry expression vector to mon-
itor the transfection efficiency and the GFP signal is analyzed within the
mCherry positive population. The background fluorescence was estimated
by using a crRNA-less, inactive AsCpf1 nuclease expression vector as neg-
ative control andwas subtracted from each sample. Three parallel transfec-
tions were made for each case. Tukey-type notched boxplots by BoxPlotR
(53): center lines show the medians; box limits indicate the 25th and 75th
percentiles; whiskers extend 1.5 times the interquartile range from the 25th
and 75th percentiles; notches indicate the 95% confidence intervals for me-
dians; crosses represent sample means; data points are plotted as open cir-
cles that correspond to the different targets tested. See also Supplementary
Figure S3.
SpCas9 efficiently induced HDR-mediated integration of
the GFP ORF to these target sites (Supplementary Fig-
ure S5) suggesting that the targeted regions are available
for RNA-guided nuclease cleavage. To test the Cpf1 nucle-
ases, the Cpf1-expressing plasmids containing a crRNA tar-
geting the Prnd locus (Supplementary Table S1) were co-
transfected with the donor plasmid and the number of GFP
expressing cells were monitored two weeks later when the
transient GFP expression from the transfected donor plas-
mid decreased to background level. The background flu-
orescence was at equally low level in case of the two con-
trol samples, where the Cpf1 nucleases were co-transfected
with either a plasmid containing no corresponding homol-
ogy arms (pHRdonor-EGFP-Sho1000), or where inactive
nucleases were co-transfected with the donor plasmid (Sup-
plementary Figure S6). These indicate that Cpf1 nuclease
activity does not result in any significant fluorescence origi-
nating from non-homology mediated on- or off-target inte-
grations with these targets that would exceed the random-
integration background level. Figure 2 shows that all four
nucleases canmediateHDR inmouseN2a cells, although to
a different extent. Out of the sixPrnd targets tested, LbCpf1
Figure 2. Cpf1 nucleases inducedHDRat various genomic cleavage sites in
N2a cells. Percentages of GFP fluorescent cells after HDR mediated inte-
gration of a donor GFP cassette are shown. The efficiencies of Cpf1 nucle-
ases (blue – LbCpf1, orange – AsCpf1, green – FnCpf1, yellow –MbCpf1)
in inducing HDR mediated integration were measured on six mouse dop-
pel genomic targets. The nuclease vector and the homologous recombina-
tion donor molecule with the corresponding homologous arms were co-
transfected into N2a cells. As negative control, the homologous recombi-
nation donor without the corresponding homologous arms was used. On
the 14th day after transfection, GFP positive cells were counted. The cor-
responding negative control was subtracted from each sample. Three par-
allel transfections were made for each sample. Two days after transfection
all the samples made on the same day showed similar GFP positive cell
counts. This GFP fluorescence was used to normalize the results for varia-
tion in transfection efficiency. Tukey-type notched boxplots by BoxPlotR
(53): center lines show the medians; box limits indicate the 25th and 75th
percentiles; whiskers extend 1.5 times the interquartile range from the 25th
and 75th percentiles; notches indicate the 95% confidence intervals for me-
dians; crosses represent sample means; data points are plotted as open cir-
cles that correspond to the different targets tested. See also Supplementary
Figure S6.
cleaved five, FnCpf1 cleaved three, AsCpf1 and MbCpf1
cleaved two targets resulting in more than 1% targeted inte-
gration above the background level (Figure 2, Supplemen-
tary Figure S6).
NHEJ-inducing activity of different Cpf1 nucleases on tar-
gets with TTTN PAM sequence
We examined the NHEJ-inducing activity of different Cpf1
nucleases by transfecting HEK-293.GFP cells with both a
nuclease expressing plasmid and a crRNA expressing plas-
mid exploiting a GFP disruption assay (47). Because of
the rarity of the TTTV PAM sequences, only two targets
with TTTV PAM sequence (GFP target 1 and GFP tar-
get 2) are present in the GFP sequence. All four nucle-
ases exhibited activities on both targets resulting in disrup-
tions ranging between 4 and 22%, likely reflecting different
target-dependencies (Figure 3). The results obtained here
with Cpf1 nucleases seem to be lower than those of SpCas9,
which reached∼62% disruption on average in the same cells
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Figure 3. GFP disruption mediated by different Cpf1 nucleases on targets
with TTTV PAMs in HEK-293.GFP cells. GFP disruption mediated by
different Cpf1 nucleases (blue bars: LbCpf1, orange bars: AsCpf1, green
bars: FnCpf1 and yellow bars: MbCpf1) on targets with a TTTA (GFP
target 1) or a TTTG (GFP target 2) PAM sequence. The nuclease vector
along with the corresponding crRNA expressing vector were transfected
into HEK-293.GFP cells and GFP positive cells were counted 7 days post-
transfection by flow cytometry. For controls we used either inactive Cpf1
expressing nuclease vectors or no-target crRNA expressing vectors. The
average GFP % of negative controls was 95.72 ± 1.13%. GFP disruption
activities of the nucleases were calculated as follows: 1 – (sample GFP
%/average GFP % of negative controls). Bars correspond to averages of
n = 3 parallel samples. The experiment was repeated six times and a rep-
resentative dataset is presented here.
(47); however, the low number of targets tested are not suf-
ficient to reach a definite conclusion upon their activities.
To get a more detailed characterization of the activity of
these nucleases, we choose to test the indel-inducing activity
of Cpf1 nucleases on 17 human endogenous genomic target
sites (Supplementary Table S1) using HEK293 human cells.
A nuclease expressing plasmid along with a cognate crRNA
expressing plasmid was transfected into HEK293 cells and
their genomic DNA was analyzed by next-generation se-
quencing. The four nucleases exhibited activities on all tar-
gets examined (Figure 4 and Supplementary Figures S7 and
S8) in line with our former disruption results (Figure 3).
However, Lb- and AsCpf1 demonstrated higher activities
on these endogenous targets than Fn- and MbCpf1.
PAM requirement of different Cpf1 nucleases
Having successfully established that Fn- and MbCpf1 nu-
cleases are active in mammalian N2a and HEK-293.GFP
cells we aimed to characterize their PAM requirements by
exploiting the previously employed GFxFP reporter sys-
tem. The advantage of this system over testing a number
of genomic targets with various PAM sequences is that the
nucleotides of the PAM can be systematically varied while
employing identical protospacer sequences; therefore, the
effect of different targets on the cleavage activity can clearly
be distinguished from the PAM preferences. We varied the
four nucleotides, one at a time, at each of the four positions
of the TTTC PAM sequences of four different targets (that
are identical with targets 4, 5, 7 and 8 on Supplementary
Figure 4. Indels mediated by different Cpf1 nucleases on endogenous tar-
gets with TTTVPAMsequence inHEK293 cells. Indelsmediated by differ-
ent Cpf1 nucleases (blue bars: LbCpf1, orange bars: AsCpf1, green bars:
FnCpf1 and yellow bars: MbCpf1) on 17 endogenous targets with TTTV
PAM sequence. The nuclease vector along with the corresponding crRNA
expressing vector were transfected into HEK293 cells and indels were an-
alyzed 5 days post-transfection by deep sequencing. Three parallel trans-
fections were made for each sample. Tukey-type notched boxplots by Box-
PlotR (53): center lines show the medians; box limits indicate the 25th and
75th percentiles; whiskers extend 1.5 times the interquartile range from the
25th and 75th percentiles; notches indicate the 95% confidence intervals for
medians; crosses represent sample means; data points are plotted as open
circles that correspond to the different targets tested. See also Supplemen-
tary Figures S7 and S8.
Figure S3) and counted the GFP positive cells at the sec-
ond day post-transfection. Although we count the number
of the GFP positive cells in the transfected cell population
assessed by the co-transfection of an mCherry-expressing
plasmid, we could not account fully for the varying transfec-
tion efficiencies. To minimize the impact of different trans-
fection efficiencies on the results, the experiments to be com-
pared by the four Cpf1 nucleases were carried out side by
side on the same days. Figure 5 reveals the activities ob-
tained for each nuclease with the different PAM sequences
examined (Figures 5 and 6, Supplementary Figures S9–
S12). A clear, but not exclusive thymidine nucleotide pref-
erence is apparent at PAM position -2 and -3 for all four
nucleases (Figures 5B, C and 6B, C). These experiments
also revealed that PAM position -1 is not unrestricted, since
thymidine is disfavored by all four nucleases, without any
further limitation on the use of the rest of the three bases
(Figures 5D and 6D). Thus, the consensus sequences of the
PAM requirement of As- and LbCpf1 is TTTV (V: all but
T); although cytosine is also tolerated to some extent as a
second option at position -3 and -2 (Figures 5 and 6 blue,
Supplementary Figures S9–S12). Fn- and MbCpf1 nucle-
ases seem to possess very similar PAM preferences (Figures
5 and 6). To be able to clearly distinguish whether Fn- and
MbCpf1 really possess a more relaxed sequence require-
ment at position -4 in mammalian cells as was suggested
by in vitro cleavage assays (23) and by PAM-SCANR in
bacteria (48), we examined their base preferences explor-
ing eight additional targets. Interestingly, we did not find
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Figure 5. PAM requirement of Lb-, As-, Mb- and FnCpf1 nucleases. Percentages of GFP positive cells counted above the background level, resulting
from the action of various nucleases on targets with different PAM sequences. Four or twelve (indicated as n) randomly picked targets with different
PAM sequences (A) NTTC PAM sequence, (B) TNTC PAM sequence, (C) TTNC PAM sequence, (D) TTTN PAM sequence) cloned into the pGF-ori-FP
vector were tested using the GFxFP assay (19). The target vectors along with the corresponding nuclease vector were transfected into N2a cells and GFP
positive cells were counted 2 days after transfection. All samples were also cotransfected with an mCherry expression vector to monitor the transfection
efficiency and the GFP signal was analyzed within the mCherry positive population. The background fluorescence was assessed by using a crRNA-less,
inactive AsCpf1 nuclease expression vector as negative control and was subtracted from each sample. Three parallel transfections were made for each case.
Tukey-type notched boxplots by BoxPlotR (53): center lines show the medians; box limits indicate the 25th and 75th percentiles; whiskers extend 1.5 times
the interquartile range from the 25th and 75th percentiles; notches indicate the 95% confidence intervals for medians; crosses represent sample means; data
points are plotted as open circles that correspond to the different targets tested. See also Supplementary Figures S9–S12.
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Figure 6. Summary of PAM requirement of Lb-, As-, Mb- and FnCpf1 nucleases. Ratios of activities of the four nucleases averaged over targets in which
the nucleotides have been varied systematically at one of the positions of the TTTN PAM sequence. Base preference at (A) -4; (B) -3; (C) -2; (D) -1 PAM
positions. Red: thymidine, blue: cytosine, green: adenine, gray: guanine. See also Supplementary Figures S9–S12.
sharp differences among the base preferences for this PAM
position of the four nucleases. All four Cpf1 nucleases fa-
vor a T nucleotide at position -4, although in a lesser extent
than in position -3 or -2. This preference is less pronounced
for Fn- and MbCpf1 (Figure 6A, Supplementary Figures
S9–S12) suggesting that As- and LbCpf1 have a more re-
laxed, while Fn- and MbCpf1 have a stricter sequence re-
quirement in mammalian cells, as compared to when either
under in vitro conditions or in bacterial system (23,48). Our
approach also revealed that the Cpf1 nuclease’s PAM pref-
erences are target-dependent (Supplementary Figures S9–
S12).
Activities of different Cpf1 nucleases on targets with various
VTTV PAMs
Although we could not verify that Fn- and MbCpf1 nucle-
ases require only two-nucleotide-long PAM sequences by
employing the GFxFP assay in mouse N2a cells, we ana-
lyzed the activity of the four Cpf1 nucleases using the dis-
ruption assay [HEK-293.GFP cells, (47)] on 16 different tar-
gets with various VTTV PAMs (CTTC, CTTG, GTTC and
GTTGPAMs; GFP target 3–18 on Figure 7). On half of the
targets none of the four Cpf1 nucleases induce GFP disrup-
tion exceeding 5% (target 3, 7, 9–13, 16 on Figure 5). On the
rest, Lb- and FnCpf1 result in higher indel-inducing activ-
ity on a target-dependent manner (Figure 7). Interestingly,
FnCpf1, in contrast to LbCpf1, shows higher activity on the
four targets with GTTV PAM (GFP target 15–18 on Figure
7) that is consistent with its slight preference for G in posi-
tion -4 seen on Figure 5 and reported in (49).
Engineered RVR mutants of Fn- and MbCpf1 with altered
PAM specificities
Since neither Fn- nor MbCpf1 proved to utilize a shorter
TTN PAM sequence, we turned to another approach to
lessen the stringency of the PAM requirement of Cpf1 nu-
cleases. Recently, it was reported that mutating the serine
542, lysine 548 and asparagine 552 amino acids to arginine-
valine-arginine (RVR mutant) alters the PAM specificity of
AsCpf1 toward TATVPAMs, therefore expanding the num-
ber of available targets ofAsCpf1 (44).We proposed that the
analogous mutations (FnCpf1: N607R+K613V+N617R,
MbCpf1: N576R+K582V+N586R) will alter the PAM
specificity of Fn- and MbCpf1 too (Supplementary Figure
S13). As we found that Cpf1s may have different activity
and PAM preference on different targets (Supplementary
Figures S9–S12), we expected that these mutations would
become a useful complement to the existing RVR mutants
of As- and LbCpf1. We introduced these mutations into
Fn- and MbCpf1 nucleases and analyzed their PAM re-
quirements in comparison to the As- and LbCpf1 vari-
ants, as well as to the corresponding wild-type (WT) pro-
tein on four different targets (targets 4, 5, 7 and 8 on Sup-
plementary Figure S3) in the GFxFP assay. The mutations
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/46/19/10272/5103950 by Sem
m
elw
eis U
niversity user on 06 M
arch 2019
Nucleic Acids Research, 2018, Vol. 46, No. 19 10279
Figure 7. GFP disruptionmediated by different Cpf1 nucleases on targets with NTTVPAMs inHEK-293.GFP cells. GFP disruptionmediated by different
Cpf1 nucleases (blue bars: LbCpf1, orange bars: AsCpf1, green bars: FnCpf1 and yellow bars: MbCpf1) on a range of different targets with an NTTV
PAM sequence (GFP target 1–18). The nuclease vector along with the corresponding crRNA expressing vector were transfected into HEK-293.GFP cells
and GFP positive cells were counted 7 days post-transfection by flow cytometry. For controls we used either inactive Cpf1 expressing nuclease vectors or
no-target crRNA expressing vectors. GFP disruption activities of the nucleases were calculated as follows: the measured percentage of GFP-positive cells
for each sample was subtracted from the total average obtained on the controls. Bars correspond to averages of n= 3 parallel samples. The experiment was
repeated two times and a representative dataset is presented here.
Figure 8. Activity of WT and RVR mutants on targets with TATC PAM sequence in N2a cells. We compared the activity of WT and RVR mutant Cpf1
nucleases on targets with TATC PAM sequences in a GFxFP assay. Percentages of GFP positive cells counted above the background level resulting from
the action of As- (orange), Lb- (blue), Fn- (green) andMbCpf1 (yellow) are shown. The target vectors along with the corresponding nuclease vectors were
transfected into N2a cells and GFP positive cells were counted 2 days post-transfection. All samples were also cotransfected with an mCherry expression
vector to monitor the transfection efficiency and the GFP signal was analyzed within the mCherry positive population. The background fluorescence was
estimated by using a crRNA-less, inactive LbCpf1 nuclease expression vector as negative control and was subtracted from each sample. Three parallel
transfections were made for each case. Error bars show the mean ± standard deviation of percentages measured in n = 3 independent transfections. See
also Supplementary Figure S14.
altered the PAM specificities in a similar manner for all
four variants affecting the -3 position (TTTV) of their PAM
sequences. Compared to the WT Cpf1 nucleases all RVR
mutants have an elevated activity on targets with TATC
PAMs that are comparable to that of the WT Cpf1 nucle-
ases on the same targets with the canonical TTTV PAM
(Figures 8 and 9, Supplementary Figure S14). This is in
accord with the results of Gao et al. (44). Their activity
on targets with TCTC PAMs slightly decreased, while on
targets with TGTC PAMs slightly increased in a nuclease-
and target-dependentmanner (Figure 9 and Supplementary
Figure S14). Themutation had no effect on the PAMprefer-
ence at position -4 (NTTV; Supplementary Figures S15 and
S16). Interestingly, in these experiments, all the RVR mu-
tants retained their activity on TTTC PAMs comparable to
those of theWT proteins (Figure 9 and Supplementary Fig-
ure S14) as reported earlier for AsCpf1 (45). Since the RVR
mutants recognize targets with both A or T at position -3 of
the PAM sequences with comparable activities on the same
targets, we suggest that a TWTV sequence (where W is A
or T and V is G, C or A) better describes their PAM pref-
erences. We verified this on four different genomic targets
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Figure 9. Comparison of base preference of WT and RVR mutant Cpf1s
at PAM position -3. Ratios of activities of the four nucleases averaged over
targets in which the nucleotides have been varied systematically at PAM
position -3 (TNTC). Red: thymidine, blue: cytosine, green: adenine, gray:
guanine. See also Supplementary Figure S14.
with either TTTV (GFP target 1, 2) or TATV (GFP target
19, 20) PAM sequences in comparison to the WT proteins
in HEK-293.GFP cells (Figure 10).
Engineered RR mutants of Fn- and MbCpf1 with altered
PAM specificities
Gao et al. reported another mutation combination
(S542R+K607R, RR mutant), which also altered the PAM
preferences of AsCpf1 resulting in increased activity on
targets with TYCV PAMs (44). We generated the analogous
RR mutants of Fn- and MbCpf1 (Supplementary Figure
S13) and compared their PAM preferences to that of As-
and LbCpf1 nucleases in GFxFP assay on eight targets
(target 4–10 and 12 on Supplementary Figure S3). We
found that their activity toward targets with the ”canoni-
cal” TTTC PAMs have not changed much although for the
RR mutants of As- and FnCpf1 a slight decrease can be
observed (Figure 11, first column, Supplementary Figure
S17). Analyzing PAM position -3 (TNTC), we confirmed
that all four WT Cpf1 nucleases exhibit some activity on
targets with TCTC PAM [Figures 5 and 11, Supplementary
Figures S9–S12, S17 (23,31)]. The RR mutations slightly
increase their tolerance on a target dependent manner in
the case of Lb- and MbCpf1, but not for As- and FnCpf1
nucleases (Figure 11, second column, Supplementary
Figure S18). Analyzing PAM position -2, we corroborate
our earlier results (Figure 5) that all WT Cpf1 nucleases
have low and target-dependent activity toward targets
with TTCC PAMs (Figure 11, third column). The RR
variants exhibit increased activity on many of the same
targets, although this difference is less prominent in the
case of Mb- and FnCpf1 nucleases (Figure 11, third col-
umn, Supplementary Figures S19 and S20). All WT Cpf1
nucleases have low target dependent activity on targets
with C at both PAM positions -2 and -3 (TCCC PAMs,
Figure 11, fourth column, Supplementary Figure S21) in a
target-dependent manner similar to those seen with PAMs
containing C in just one of the two positions (TCTC and
TTCC, Figure 11, second and third column). In contrast,
the four RR mutants have elevated activity on targets with
TCCC PAMs, comparable to that which WT nucleases
exhibit on the same targets with the ”canonical” TTTC
PAMs (Figure 11, fourth column). Interestingly, the data of
each RR variant with TTCC and TCCC PAM in Figure 11
show an almost identical pattern. This suggests that the RR
mutations actually affect the preferences for the -2 position
of the PAM of these four nucleases with a smaller effect
on the position -3. Next, we examined the effect of these
RR mutations on the PAM specificities of these four Cpf1
nucleases toward single nucleotide changes at position -4.
These mutations did not alter their tolerance; however, the
overall activity of As- and FnCpf1 slightly decreased in a
target- and nuclease-dependent manner (Supplementary
Figures S22–S23).
Next, we monitored the activities of the four RR variants
on genomic targets with TCTV, TTCV and TCCV PAMs in
comparison to the four WT proteins in a disruption assay
using HEK-293.GFP cells (Figure 12). All four mutant nu-
cleases demonstrated increased activities compared to the
WT proteins on targets with TTCV or TCCV PAMs in a
nuclease- and target-dependent manner, although these ef-
fects were much less prominent with the FnCpf1 mutant
(Figure 12B, C). In contrast, on targets with a TCTV PAM
a smaller effect is apparent, three variants (Lb-, Mb- and
FnCpf1 RR variants) show increased activities, and among
them, the RR variant of LbCpf1 is the most active when
compared to the WT nucleases (Figure 12A). These results
are in accord with the PAM preferences seen in the GFxFP
assay (Figure 11).
DISCUSSION
Cpf1 proteins are promising alternatives to the widely used
Cas9 nucleases in genome editing applications. Among
them, As- and LbCpf1s are employed in most of the appli-
cations at present, despite the rarity of their TTTV PAM
sequence in the genome of higher eukaryotic organisms
that limits their applications. Their potential alternatives,
Fn- and MbCpf1 are reported to require shorter, two-
thymidine-long PAMsequences and exhibited high cleavage
activity in vitro, while their activity was hardly detectable in
mammalian cells (23). In contrast, one of them, FnCpf1, in
the presence of a DNA repair template, was demonstrated
to induce precise gene insertions as well as indel mutations
at the target site in the rice genome (40,41) and, in an-
other study, in tobacco (50).More recently, Tu et al. showed
that FnCpf1 exhibits indel-inducing activity in human cells
on targets with KYTV PAM sequences (49). Here, we ex-
amined the activity of Fn- and MbCpf1 using two differ-
ent methods, a plasmid-based assay and one exploiting ge-
nomic targets and revealed that in mammalian N2a cells
both Fn- andMbCpf1 nucleases can be as useful as As- and
LbCpf1 to induce HDR. This conclusion upon their po-
tential usefulness was further supported on genomic targets
in another mammalian cell line (HEK-293.GFP) exploiting
NHEJ repair. Interestingly, when their indel-inducing activ-
ities were tested on endogenous targets by next-generation
sequencing, Lb- and AsCpf1 performed better. By compar-
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Figure 10. GFP disruption mediated by WT and RVR Cpf1 variants on targets with TWTV PAMs in HEK-293.GFP cells. GFP disruption mediated
by WT (black) and RVR (dotted) Cpf1 variants on targets with TWTV PAM sequence (TTTV PAM: GFP target 1–2, gray background; TATV PAM:
GFP target 19–20, no background). The nuclease vector along with the corresponding crRNA expressing vector were transfected into HEK-293.GFP cells
and GFP positive cells were counted 7 days post-transfection by flow cytometry. For controls we used either inactive Cpf1 expressing nuclease vectors or
no-target crRNA expressing vectors. GFP disruption activities of the nucleases were calculated as follows: the measured percentage of GFP-positive cells
for each sample was subtracted from the total average obtained with the controls. Bars correspond to averages of n = 3 parallel samples.
ing the four nucleases on identical targets using the differ-
ent assays, a nonidentical, although similar target selectiv-
ity is discernible that may explain why the activity of Fn-
andMbCpf1 nucleases was not revealed in earlier studies in
mammalian cells when only one or additional two targets,
were examined (23,29). This also suggests that some other
Cpf1 nucleases investigated by the Zetsche study (23) may
prove to be useful in mammalian cells if they are tested on
increased number of targets.
Our experiments also suggest a slightly different PAM
requirement for As- and LbCpf1 nucleases than that was
originally described (23). We confirm that both nucleases
prefer T in position -2, -3 and -4, but disfavor it in posi-
tion -1. The latter effect is more evident with AsCpf1 than
with LbCpf1 (Figures 5 and 6). A slight preference for A at
position -1 may also be observable for AsCpf1, but not for
LbCpf1 (Figure 5), in line with the previous study (31). In
contrast, we found that LbCpf1 is slightly more permissive
for a C nucleotide in either the second or fourth positions
than AsCpf1, also in accord with (31). Our approach, us-
ing 96 PAM-target combinations for each nuclease, appears
to reveal the same features of PAM requirements for Lb-
and AsCpf1 as the more systematic study of Kim et al. ex-
ploring approximately 1100 combinations (31), underscor-
ing the validity of our approach. By the same argument the
PAM preferences for the Fn- and MbCpf1 nucleases are
also likely to be generally valid.
Based on the crystal structure of FnCpf1 with crRNA
and target DNA, interactions of the protein with positions
-2 and -3 but not the first base pair of the PAM sequence
were reported supporting a TTN PAM requirement (51,52)
as was suggested in (23) for both Fn- and MbCpf1 based
on in vitro assays. Here, we confirm the T preferences for
both the second and third positions concerning both nucle-
ases. However, our results further refine the understanding
of the PAM requirements of both nucleases in mammalian
cells. Both Fn- and MbCpf1 disfavor T nucleotide in posi-
tion -1 although MbCpf1 is somewhat more tolerant, simi-
lar to LbCpf1 (Figures 5 and 6). By contrast, they prefer a
T nucleotide in position -4 leading to the same TTTV PAM
sequence that has been established for As- and LbCpf1. The
structural bases of this preference are not fully understood.
However, the -4 T preference of Fn- and MbCpf1 is less
prominent than that of As- and LbCpf1. Fn- and MbCpf1
are also permissive for a C nucleotide as a secondary choice
at positions -2 and -3 of TTTV (Figures 5 and 6). Interest-
ingly, the permissiveness of all four nucleases for a C nu-
cleotide as a second choice at positions -2, -3 or -4 or aGnu-
cleotide as a second choice for FnCpf1 at position -4 varies
with the target sequences and shows an apparent target de-
pendency (Supplementary Figures S9–12). This might also
explain the slight differences for the -4 PAM preferences of
FnCpf1 reported by Tu et al. (49), systematically examining
two targets in contrast to the 12 different targets exploited in
this study. Although none of the two Cpf1 nucleases proved
to possess only a shorter TTN PAM in mammalian cells,
due to their differing activities on various targets, these ex-
periments established Fn- and MbCpf1 as useful comple-
ment to As- and LbCpf1 for genetic engineering in mam-
malian cells.
To further increase the number of available targets of
Cpf1 nucleases in higher eukaryotic genomes we generated
the RVR and RR variants of Fn- and MbCpf1 analogous
to those of As- and LbCpf1 (44) based on their sequence
homology (Supplementary Figure S13). The RVR and RR
mutations in Fn- andMbCpf1 resulted in PAM recognition
patterns very similar to those of As- and LbCpf1 analo-
gous mutants. Thus, our results suggest that despite some
sequence differences in the implicated region between the
four Cpf1s, these nucleases employ an identical mechanism
for PAM recognition.
One interesting outcome of the side-by-side comparison
of the mutants to the WT nucleases is that the RVR mu-
tant variants, beside gaining new PAM recognition abili-
ties, retained activity on targets with the canonical TTTV
PAM comparable to that of the WT proteins as reported
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Figure 11. Activity of WT and RR mutants on targets with TYYC PAM sequences in N2a cells. We compared the activity of WT and RR mutant Cpf1
nucleases on targets with TYYC PAM sequences (first column: TTTC, second column: TCTC, third column: TTCC, fourth column: TCCC) in a GFxFP
assay. Percentages of GFP positive cells counted above the background level resulting from the action of As- (orange), Lb- (blue), Fn- (green) andMbCpf1
(yellow) are shown. The target vectors along with the corresponding nuclease vectors were transfected into N2a cells and GFP positive cells were counted
2 days post-transfection. All samples were also cotransfected with an mCherry expression vector to monitor the transfection efficiency and the GFP
signal was analyzed within the mCherry positive population. The background fluorescence was estimated by using a crRNA-less, inactive LbCpf1 nuclease
expression vector as negative control and was subtracted from each sample. Three parallel transfections were made for each case. Error bars show the mean
± standard deviation of percentages measured in n = 3 independent transfections. See also Supplementary Figures S17–S21.
earlier for AsCpf1 (45). Thus, our results further refine
our understanding of the PAM preferences of this variant
of LbCpf1 and suggest that these RVR mutants are capa-
ble of efficiently mediating genome editing on targets with
TWTV PAM. For RR mutants, the LbCpf1 variant utilizes
a TYYV PAM, while the AsCpf1 variants utilize TTYV or
TCCV PAM, since the activities of the RR mutant of As-
Cpf1 on the same targets with TCTV PAM do not seem
to exceed those of the corresponding WT proteins. The
RR mutant of FnCpf1 is more similar to LbCpf1, whereas
MbCpf1 is more similar to AsCpf1.
In accord with the observed target dependency of the
PAM recognition of theWTCpf1s, the mutations increased
the tolerances of the variants to the altered PAMs in a
nuclease- and target-dependent manner. Thus, although the
PAM preferences of the mutants of Fn- and MbCpf1 gen-
erated here are very similar to those of the As- and LbCpf1
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Figure 12. GFP disruption mediated by WT and RR Cpf1 variants in HEK-293.GFP cells. GFP disruption mediated by WT (black) and RR (striped)
Cpf1 variants on targets with (A) TYTV, (B) TTYV or (C) TTTV/TCCV PAM sequences (TTTV PAM: GFP target 1–2, gray background; TCTV PAM:
GFP target 21–24, TTCVA PAM: GFP target 25–28, TCCV PAM: GFP target 29–32, no background). The nuclease vector along with the corresponding
crRNA expressing vector were transfected into HEK-293.GFP cells and GFP positive cells were counted 7 days post-transfection by flow cytometry. For
controls we used either inactive Cpf1 expressing nuclease vectors or no-target crRNA expressing vectors. GFP disruption activities of the nucleases were
calculated as follows: the measured percentage of GFP-positive cells for each sample was subtracted from the total average obtained with the controls.
Bars correspond to averages of n = 3 parallel samples.
variants, they increase the number of the targets that are
available for genome modifications by Cpf1s.
In conclusion, our experiments demonstrate that Fn- and
MbCpf1 can be used to perform genome engineering tasks
with a considerable efficiency in mammalian cells. However,
neither Fn-, nor MbCpf1 demonstrate a general higher ac-
tivity on targets with VTTV PAM sequences compared to
As- or LbCpf1, suggesting that the sequence requirements
in mammalian cells for As- and LbCpf1 are more relaxed
than those identified in vitro whereas those for Fn- and
MbCpf1 are stricter. Nevertheless, since their target speci-
ficities are not identical and because there is a target de-
pendency of their PAM preferences, they seem destined to
become useful complements to As- and LbCpf1. We also
generated the RVR and RR mutant variants of both Fn-
and MbCpf1 and characterized them along with the analo-
gous As- and LbCpf1 variants and the corresponding WT
proteins. Our results revealed that the mutations altered
the PAM preferences of all four Cpf1s in a similar man-
ner and redefined the known PAM preferences of the As-
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and LbCpf1 variants: RVR mutants recognize targets with
TWTVPAMs, while RRmutants prefer targets with TYYV
or TTYV/TCCV PAMs. We also showed here that the mu-
tant variants retained their activity on the canonical TTTV
PAM, suggesting that they are superior alternatives with a
more relaxed PAM recognition compared to the WT pro-
teins in most applications.
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Supplementary Data are available at NAR Online.
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